Updated Guidance For Treating ACHD Patients Released
Specifically, the guideline presents a new classification system for ACHD patients that retains the traditional classification based on the structural complexity of the disease while taking into account the patient’s functional status and other factors, including the presence of cardiovascular and non-cardiovascular problems. The new system is intended to capture the complexity of ACHD in terms of both anatomy and physiology, rather than anatomy alone. It also provides the basis for making lesion-specific recommendations for interval clinical follow-up and testing modalities such as electrocardiograms, transthoracic echocardiography, cardiovascular magnetic resonance and exercise testing.
The need for specialized care is also highlighted throughout the guideline, with authors noting that patients with significant ACHD who are cared for in ACHD centers have better outcomes than those cared for in centers without ACHD expertise.
New Post-ACC.18 Content on ACC.org
ACC has been working with the FDA to provide volunteers for an FDA Network of Experts issue regarding the diagnosis of Afib through wearable sensors. ACC has provided them with several experts but they are interested in expanding to a few generalists and are asking for ACC to provide those generalists to ask about their thoughts and practices in this area.
Volunteering does not guarantee selection as the FDA is asking for the ACC to supply names and CVs for interested participants and they will work to determine eligibility.
If you are interested please send your CV to Joseph Cody (
), and ACC will collect volunteers and send them to staff at the Division of Cardiac Devices at the FDA.
New 'Reduce the Risk: PCI Bleed Quality Campaign' Aims to Close Gaps in PCI Patient Care
The ACC recently launched the
Reduce the Risk: PCI Bleed
quality campaign to help hospitals and clinicians minimize PCI-associated bleeding risks and encourage widespread adoption of evidence-based best practices. Leveraging the power of the
, Reduce the Risk: PCI Bleed offers the tools you need to anticipate, prepare and save lives, including self-assessment resources and a custom data dashboard to compare your data. In addition, participation in this program counts as a high-weight Improvement Activity for physicians and Advanced Practice Practitioners participating in the
Merit-Based Incentive Payment System (MIPS)
Reduce the Risk: PCI Bleed and be recognized as a Quality Leader! Participation is easy and at no additional cost to CathPCI Registry participants. Learn more at
Leadership Forum 2019 co-locating with CV Summit in Orlando, FL at the Hilton Bonnet Creek
The Forum and Summit will be
February 14-16 and a draft schedule is below.
Please note, these dates and times are approximate and subject to change.
Wednesday, February 13, 2019
• 5-8 pm
ONLY for Incoming Leaders elected in the fall of 2018 - Orientations
Thursday, February 14, 2019
7:30 – 11:30 am – CV Summit Pre-Conference Sessions
12:00 – 1:30 pm – Leadership Keynote Luncheon
2:00 – 6:00 pm – CV Summit
6:15 – 7:15 pm Exhibitor Reception
Friday, February 15, 2019
7:30 am – 5:15 pm – CV Summit
Saturday, February 16, 2019
7:30 – 11:00 am – CV Summit Wrap Up
7:30 – 11:00 am – BOG Meeting
7:30 – 11:00 am – SSC Meeting